American Transplant Congress-Transplantation Education From Clinical Care Options

[Guest guest]

American Transplant Congress-Transplantation Education From Clinical Care Options

Transplantation Education From Clinical Care OptionsCCO is expanding to provide CME/CE-certified programming in transplantation, beginning with Conference Coverage from the American Transplant Congress in Philadelphia. Click here to review transplantation content from CCO!*Free Registration Is Required

Capsule Summaries

BENEFIT: 3-Year Data Confirm High Rate of Patient and Graft Survival With Belatacept Maintenance Immunosuppression, With Improved Renal Function vs Cyclosporine BENEFIT and BENEFIT-EXT: Pooled Safety Data Through 3 Years Reveal No New Safety Signals Associated With Belatacept Costimulation Blockade Preliminary Results Suggest That Alemtuzumab Induction Followed by Belatacept and Sirolimus Maintenance Prevents Renal Allograft

Rejection and Alloantibody Formation Alefacept-Based Regimens Significantly Reduce T-Cell Memory Subsets but Associated With Increased Rejection Rates vs Control Regimen in Kidney Transplant Recipients Tofacitinib-Based Regimen as Effective at Preventing Acute Rejection of Kidney Transplant and Better Preserves Renal Function vs Cyclosporine-Based Regimen Tofacitinib-Based Regimen Better Preserves Renal Function Than

Cyclosporine-Based Regimen in Kidney Transplant Recipients Total Lymphoid Irradiation, Antithymocyte Globulin, and Donor Hematopoietic Cell Infusion Safely and Successfully Induces Tolerance After HLA-Matched Kidney Transplant mRNA Expression Profiles of Urinary Cells Correlate With and Predict Development of ACR in Renal Allograft Recipients Favorable Graft and Patient Survival Among HIV-Infected Patients Who

Received Kidney Transplant Regardless of Use of NIH Study Protocol or Center Experience HIV-Related Factors Such as HIV-1 RNA and CD4+ Cell Count Not Associated With Survival After Kidney or Liver Transplantation in HIV-Infected Individuals Proteasome Inhibitor–Based Therapy Provides Effective Reversal of Antibody-Mediated Rejection in Kidney Transplantation Vascular Endothelial Cell Biomarkers Accurately

Diagnose Cardiac Allograft Vasculopathy in Heart Transplant Recipients Virtual Cross-Matching of Sensitized Recipients in Need of Isolated Intestinal Transplant Yields Rejection and Survival Outcomes Comparable to Nonsensitized Recipients Animal Studies Suggest That Blocking T-Cell Adhesion Pathways in Addition to Costimulation Pathways May Help Overcome Costimulation Blockade-Resistant Rejection

http://Hepatitis Cnewdrugs.blogspot.com/2011/07/american-transplant-congress.html